Julia Duerr

Author PubWeight™ 8.13^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaENaC-overexpressing mice.	Am J Respir Crit Care Med	2008	1.64
2	The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease.	J Cyst Fibros	2011	1.20
3	Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.	Am J Respir Crit Care Med	2014	1.01
4	The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients.	PLoS One	2011	0.92
5	SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation.	J Clin Invest	2012	0.91
6	Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12-dependent emphysema.	Am J Respir Cell Mol Biol	2014	0.91
7	Keratinocyte growth factor and dexamethasone plus elevated cAMP levels synergistically support pluripotent stem cell differentiation into alveolar epithelial type II cells.	Tissue Eng Part A	2013	0.81
8	Bronchoalveolar sublineage specification of pluripotent stem cells: effect of dexamethasone plus cAMP-elevating agents and keratinocyte growth factor.	Tissue Eng Part A	2014	0.77